Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zwitter

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Annals of the New York Academy of Sciences|February 20, 1997
Learning from the world. The editors' perspectiveA Surbone, M Zwitter
Lung Cancer (Amsterdam, Netherlands)|June 19, 1998
A survey of the ethical considerations in randomised trials for lung cancerM Zwitter, J S Tobias
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Informed consent in European multicentre randomised clinical trials--are patients really informed?C J Williams, M Zwitter
Neoplasma|October 5, 2001
Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancerM Zwitter, T Cufer, W Wein
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1996
Total body irradiation with translation methodB Umek, M Zwitter, H Habic
British Journal of Cancer|January 1, 1996
A case-control study of Hodgkin's disease and pregnancyM Zwitter, M P Zakelj, K Kosmelj
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2003
The significance of adrenal metastases from lung carcinomaI Kocijancic, K Vidmar, M Zwitter, et al.
Neoplasma|January 12, 2018
PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapyM Vrankar, M Zwitter, I Kern, et al.
Anti-Cancer Drugs|October 14, 2005
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancerM Zwitter, V Kovac, U Smrdel, et al.
BMJ (Clinical Research Ed.)|January 23, 1999
Professional and public attitudes towards unsolicited medical interventionM Zwitter, T Nilstun, L E Knudsen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of the New York Academy of Sciences|February 20, 1997
Learning from the world. The editors' perspectiveA Surbone, M Zwitter
Lung Cancer (Amsterdam, Netherlands)|June 19, 1998
A survey of the ethical considerations in randomised trials for lung cancerM Zwitter, J S Tobias
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Informed consent in European multicentre randomised clinical trials--are patients really informed?C J Williams, M Zwitter
Neoplasma|October 5, 2001
Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancerM Zwitter, T Cufer, W Wein
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1996
Total body irradiation with translation methodB Umek, M Zwitter, H Habic
British Journal of Cancer|January 1, 1996
A case-control study of Hodgkin's disease and pregnancyM Zwitter, M P Zakelj, K Kosmelj
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2003
The significance of adrenal metastases from lung carcinomaI Kocijancic, K Vidmar, M Zwitter, et al.
Neoplasma|January 12, 2018
PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapyM Vrankar, M Zwitter, I Kern, et al.
Anti-Cancer Drugs|October 14, 2005
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancerM Zwitter, V Kovac, U Smrdel, et al.
BMJ (Clinical Research Ed.)|January 23, 1999
Professional and public attitudes towards unsolicited medical interventionM Zwitter, T Nilstun, L E Knudsen, et al.
Pageof 2